European Pharmaceutical Review

APRIL 18, 2024

What are the three main challenges of monitoring pharmaceuticals in the environment? Andreas Häner (AH): Roche, along with other pharmaceutical companies, acknowledges concerns about pharmaceuticals in the environment (PiE). The difference between detection limits and quantitation limits is very important.

Pharmaceutical Manufacturing 97

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 97

Express Pharma

DECEMBER 11, 2024

The event is a joint initiative between AIPAC, Society for Pharmaceutical Dissolution Science (SPDS), Indian Drug Manufacturers Association-MP State Board (IDMA-MP), and Madhya Pradesh State Drugs and Pharmaceutical Manufacturers Association (MPSDMA).

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 52

Express Pharma

APRIL 20, 2023

COVID-19 has sped up the digital transformation and forced pharmaceutical companies to rethink many aspects of their business. Continuous manufacturing The topic of continuous manufacturing is also discussed in frames of PHARMAP 2023. This leads to growth in the pharma industry by finding new solutions and innovations.

Packaging 52

Packaging Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 52

Quality Matters

SEPTEMBER 15, 2023

PCM not ideal for every drug Continuous manufacturing “may not be fit for every pharmaceutical manufacturing process, but it can bring some advantages in some cases” compared with traditional batch manufacturing, summarized FDA’s Adam Fisher, Ph.D., Why is continuous better? Executive Director at Eli Lilly.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies Dosage 52

European Pharmaceutical Review

NOVEMBER 8, 2022

3) policing anticompetitive settlements between competing drug manufacturers. European pharmaceutical companies targeting the US market should be aware of these pending bills and their potential impacts on market entry, intellectual property enforcement and payer access. 5) monitoring access to biosimilars.

Biosimilars 52

Biosimilars Drug Pricing Pharmaceutical Manufacturing Pharmaceutical Companies 52

Viseven

JANUARY 13, 2023

So what do exactly HEOR experts do for the pharmaceutical companies and what HEOR-collected data is used for? HEOR collects all reports about health outcomes from patients and physicians and later provides detailed analytics to healthcare providers, clinical outcomes research institutions or pharmaceutical companies.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Dosage Drug Pricing 40

Pharmaceutical Technology

FEBRUARY 9, 2023

Container Closure Integrity Testing (CCIT) is used to evaluate the ability of a pharmaceutical’s primary packaging to protect the sterility of its contents. On a regular basis, pharmaceutical manufacturers are performing CCIT during commercial production to ensure that packaging processes are operating as they should.

Packaging 52

Packaging Pharmaceutical Manufacturing Communication Pharmaceutical Companies 52

PharmaShots

FEBRUARY 27, 2023

The theme of the event was Innovation, Advanced Technology, Current Challenges & Opportunities in Pharma & Healthcare Industry under which a series of presentation sessions and panel discussions were held related to pharma trends, APIs, policy reforms, AI, metaverse, current regulatory trends and the direction of pharma and drug discovery.

Biosimilars 40

Biosimilars Diabetes Packaging Hospitals 40

GMPSOP

MAY 31, 2024

Regulatory authorities require them to produce evidence that the processes and systems are validated, critical equipment is qualified, and manufactured products are tested for purity. Pharmaceutical companies are accountable for properly warehousing, shipping their products, and guaranteeing their stability until expiry.

Documentation 59

Documentation Method Validation Pharmaceutical Companies Pharmaceutical Companies 59

Express Pharma

FEBRUARY 20, 2025

As the sector continues its rapid expansion, with a 7 per cent annual growth rate, the event will highlight the increasing reliance on contract development and manufacturing organisations (CDMOs) in bringing new therapies to market. The event will also present new industry research from Simon-Kucher.

Pharmaceutical Manufacturing 101

Pharmaceutical Manufacturing Vaccines Pharmaceutical Companies Pharmaceutical Companies 101

GMPSOP

MARCH 30, 2024

Production run charts Run charts are often used to monitor manufacturing processes. Through meticulous line clearance procedures, pharmaceutical manufacturers can uphold GMP standards and safeguard product quality and safety. When these checks are done by production staff, the check should be audited by the Quality Department.

Labelling 52

Labelling Packaging Documentation Pharmaceutical Manufacturing 52

GMPSOP

OCTOBER 28, 2023

GMP requires that all critical steps of manufacture are reliable or validated. How to perform sampling in quality control process Sampling is the removal of a presentative portion of a lot to understand the lot’s composition and characteristics. This naturally includes laboratory test methods.

Documentation 52

Documentation Method Validation Packaging Data Entry 52

Express Pharma

JANUARY 26, 2025

Scheduled to take place from January 27-30, 2025, at the World Trade Center (WTC), Dubai to be inaugurated by Satish Kumar Siven, Consul General of India to UAE, at Dubai on January 27, 2025 this event will feature participation from 65 leading Indian pharmaceutical companies.

Pharmaceutical Manufacturing 82

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies Vaccines 82

Express Pharma

MAY 6, 2024

The event brought together over 330 professionals from across the industry’s value chain Pharmaceutical Manufacturing and Packaging Congress (PHARMAP 2024) was held in Amsterdam, Netherlands on April 22-23, 2024. Among the attendees, contract manufacturing organisations, service providers and experts were present.

Packaging 105

Packaging Pharmaceutical Manufacturing Labelling Pharmaceutical Companies 105

Express Pharma

JUNE 5, 2024

Also, the proliferation of antimicrobial resistance (AMR), where overuse of antibiotics leads to resistant bacteria, making infections harder to treat Additionally, pharmaceutical manufacturing consumes substantial amounts of solvents, which are typically highly toxic chemicals, as well as heavy metals.

Pharmaceutical Manufacturing 98

Pharmaceutical Manufacturing Packaging Documentation Compounding 98

Pharmaceutical Technology

MARCH 22, 2023

In the 1990s, generic pharmaceutical companies in the European Union (EU) offshored the manufacturing of active pharmaceutical ingredients (API) primarily to China. Moreover, US Pharmacopeia issued the first-ever Medicine Supply Map to find and quantify risks in upstream pharmaceutical supply chains across the country.

Pharmaceutical Manufacturing 105

Pharmaceutical Manufacturing Packaging Communication Diabetes 105

GMPSOP

FEBRUARY 28, 2024

This article will explore the key considerations, best practices, and regulatory requirements for effective cleaning and sanitation that pharmaceutical companies must adhere to for optimal cleanliness and safety. Sometimes, pharmaceutical manufacturers employ surface profilometry to assess the roughness of stainless-steel equipment.

Documentation 98

Documentation Packaging Pharmaceutical Manufacturing Compounding 98

GMPSOP

MAY 17, 2024

This article will explore the key considerations, best practices, and regulatory requirements for effective cleaning and sanitation that pharmaceutical companies must adhere to for optimal cleanliness and safety. Sometimes, pharmaceutical manufacturers employ surface profilometry to assess the roughness of stainless-steel equipment.

Documentation 52

Documentation Packaging Pharmaceutical Manufacturing Compounding 52

European Pharmaceutical Review

AUGUST 17, 2022

Antibiotic production processes involve a risk that, if operations and waste management practices are not strictly controlled, antibiotic can leave manufacturing plants in waste water, for example, and enter the environment in concentrations that may increase the risk of AMR. Frontiers in Microbiology. Tell J, Caldwell D, Häner A, et al.

Hospitals 98

Hospitals Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 98

GMPSOP

DECEMBER 10, 2023

Particularly the printed packaging materials where product information is presented. – When new printed material to the line double-check that the correct printed material has been selected and presented to the line. Accurate packaging prevents mix-ups and complies with Good Manufacturing Practice (GMP) rules.

Packaging 40

Packaging Health and Personal Care Stores Labelling Documentation 40

GMPSOP

SEPTEMBER 27, 2023

The practice of calling a piece of equipment clean just because it looks clean is not acceptable in the pharmaceutical manufacturing process. The amount of residue if present is assessed to have no harmful effect on human use. Why is cleaning validation required? NOEL stands for No Observable Effect Level in cleaning validation.

Method Validation 98

Method Validation Documentation Pharmaceutical Manufacturing Dosage 98

GMPSOP

JULY 31, 2023

We will present the rationale behind the qualification decision and reference that with the GAMP (Good Automated Manufacturing Practice) categories in support of the decision you will make. These requirements mandate that pharmaceutical companies thoroughly document OQ protocols, testing methods, acceptance criteria, and results.

Documentation 52

Documentation Dosage Labelling Data Entry 52

Drug Patent Watch

DECEMBER 17, 2024

The Evolving Role of CDMOs in the Pharmaceutical Industry Gone are the days when CDMOs were mere service providers. Today, they’re strategic partners in drug development and manufacturing, offering end-to-end solutions that can make or break a pharmaceutical company’s success.

Drug Development 90

Drug Development Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 90

European Pharmaceutical Review

FEBRUARY 20, 2025

Increased API costs may force some manufacturers to reduce output or exit the market entirely, reducing competition and potentially driving price inflation. For branded pharmaceutical companies, the impact may be less immediate due to their larger profit margins.

Drug Pricing 20

Drug Pricing Pharmaceutical Manufacturing Generic Medicine Hospitals 20